Signals of Change: How Biomarkers Are Reshaping Oncology and Healthcare Delivery
Biomarkers are crucial for confirming diagnoses, predicting disease progression, and tailoring therapeutic modalities, with recent research focusing on genomics, proteomics, and metabolomics.
Cancer, a leading cause of global mortality, requires advancements in diagnostic and therapeutic strategies, with cancer biomarkers becoming essential to diagnosis and treatment in modern oncology.
These biological molecules, such as proteins, genes, or metabolites, indicate the presence, progression, or behavior of cancer, driving the field forward with cutting-edge technologies and innovative approaches.
Emerging innovations are pushing oncology toward a more proactive, personalized, and economically sound approach.
An editorial published in Cancers in September 2025 provided a review of recent progress in cancer biomarker development, exploring the impact of these advancements.
Author: Walid Qoronfleh, Ph.D.
Author's summary: Biomarkers are revolutionizing oncology and healthcare delivery.
More News
- “Highly rated” Man Utd youngster could be the solution for Rúben Amorim’s biggest problem
- TBA, Appraisal, Reverse Mortgage Tools; STRATMOR on AI and Competition; Can the CFPB be Willed Away?
- Fabrizio Romano has terrible news for Tottenham midfielder
- EU Updates Age Verification Standards for Minors
- Manchester United’s stance on Kobbie Mainoo leaving Old Trafford in January revealed
- Ferrari’s Elkann issues statement – fully backs Vasseur
- Brewers Go Out With a Whimper in NLCS